Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort
Alexandre Louvet, Valérie Bourcier, Isabelle Archambeaud, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 501-512
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 296
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 56
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hannes Hagström, Ying Shang, Hannes Hegmar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 944-956
Closed Access | Times Cited: 33
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 30
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 28
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 21
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
Brian P. Lee, Katie Witkiewitz, Jessica L. Mellinger, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 626-645
Open Access | Times Cited: 19
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease
Katrine Thorhauge, Georg Semmler, Stine Johansen, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 23-32
Open Access | Times Cited: 15
Management of alcohol use disorder in patients with chronic liver disease
Jessica L. Mellinger, Anne C. Fernandez, Gerald Scott Winder
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 15
Non-invasive tests for alcohol-associated liver disease
Mads Israelsen, Wiramon Rungratanawanich, Maja Thiele, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1390-1407
Closed Access | Times Cited: 10
Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis
Jordi Gratacós‐Ginès, Pol Bruguera, Martina Pérez, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 368-379
Open Access | Times Cited: 20
MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event
Marta Tonon, Lorenz Balcar, Georg Semmler, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1149-1158
Closed Access | Times Cited: 16
Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis
Wen Hui Lim, Phoebe Wen Lin Tay, Cheng Han Ng, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 6, pp. 730-741
Open Access | Times Cited: 6
Noninvasive assessment of hepatic decompensation
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 14
Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study
Philippe Sultanik, Guillaume Lherault, Charlotte Bouzbib, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 796-810
Open Access | Times Cited: 5
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States
Robert J. Wong, Patrick Gagnon‐Sanschagrin, Zeev Heimanson, et al.
Clinical and Translational Gastroenterology (2025)
Open Access
Larsucosterol Moves Forward as a Treatment Contender for Alcohol-Associated Hepatitis
Praveena Narayanan, Michael R. Lucey
NEJM Evidence (2025) Vol. 4, Iss. 2
Closed Access
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors
Francisco Capinha, Sofia Carvalhana, Helena Cortez‐Pinto
Digestive Diseases and Sciences (2025)
Open Access
Cracking the code of HBV persistence: cutting-edge approaches to targeting cccDNA in chronic hepatitis B with or without pyogenic liver Abscesses
Saeed Umar, Zahra Zahid Piracha, Mahmood A. Khan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease
Jessica A. Ratner, Hanna Blaney, Darius A. Rastegar
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 3
Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder
Lamia Haque, Lorenzo Leggio
Hepatology (2024) Vol. 80, Iss. 6, pp. 1408-1423
Closed Access | Times Cited: 3
Is there a safe limit for consumption of alcohol?
Jessica Musto, Randall Brown, Michael R. Lucey
Journal of Hepatology (2024)
Closed Access | Times Cited: 3
Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist
Ming‐Lun Yeh, Jee‐Fu Huang, Chia‐Yen Dai, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 8, pp. 431-439
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top